Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1332-1336

  Bian, Mei Lu ^a   Cheng, Jiao Ying ^a   Li, Ma ^a   Xiao, Cong ^a   Jun, Liu ^a   Ying, Chen ^a   Xi, Chen ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Cervical cancer screening; Cervical intraepithelial lesions; Genotyping; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENOTYPING TECHNIQUE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84884810941     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1309     Document Type: Article

References (27)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU and zur Hausen H: Classification of papillomaviruses. Virology 324: 17-27, 2004.
2. st International Papillomavirus Conference in Mexico City, 20-26 February 2004. Papillomavirus Rep 15: 121-123, 2004.
3. Kitchener HC, Almonte M, Thomson C, et al: HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 10: 672-682, 2009.
4. McLachlin CM: Human papillomavirus in cervical neoplasia. Role, risk factors, and implications. Clin Lab Med 20: 257-270, 2000.
5. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R and Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121: 621-632, 2007.
6. Bulkmans NW, Berkhof J, Rozendaal L, et al: Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370: 1764-1772, 2007.
7. Dillner J, Rebolj M, Birembaut P, et al: Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337: a1754, 2008.
8. Mayrand MH, Duarte-Franco E, Rodrigues I, et al; Canadian Cervical Cancer Screening Trial Study Group: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579-1588, 2007.
9. Naucler P, Ryd W, Törnberg S, et al: Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357: 1589-1597, 2007.
10. Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA and Kornegay J: Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol 47: 3344-3347, 2009.
11. Wright TC Jr, Massad LS, Dunton CJ, et al; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference: 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197: 346-355, 2007.
12. Bosch FX and de Sanjosé S: Chapter 1: Human papillomavirus and cervical cancer burden and assessment of causality. J Natl Cancer Inst Monogr 31: 3-13, 2003.
13. Clifford GM, Sm it h JS, Plum mer M, Mu ñoz N a nd Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73, 2003.
14. Mǔoz N, Bosch X, de Sanjosé S, et al: Epidemiologic classification of Human Papilloma Virus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003.
15. Poljak M, Ostrbenk A, Seme K, et al: Comparison of clinical and analytical performance of the Abbott realtime high risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening. J Clin Microbiol 49: 1721-1729, 2011.
16. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC and Castle PE: Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103: 368-383, 2011.
17. Apgar BS, Zoschnick L and Wright TC Jr: The 2001 Bethesda System terminology. Am Fam Physician 68: 1992-1998, 2003.
18. Ermel A, Qadadri B, Morishita A, et al: Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquareMicroarray Assay. J Virol Methods 169: 154-161, 2010.
19. Sherman ME, Lorincz AT, Scott DR, et al: Baseline cytology, human papilomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95: 46-52, 2003.
20. Gage JC, Sadorra M, Lamere BJ, et al; PaP Cohort Study Group: Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear assay HPV DNA tests. J Clin Microbiol 50: 61-65, 2012.
21. Burd EM: Human papillomavirus and cervical cancer. Clin Microbiol Rev 16: 1-17, 2003.
22. Kaliterna V, Lepej SZ and Vince A: Comparison between the Abbott RealTime high risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens. J Med Microbiol 58: 1662-1663, 2009.
23. Kovacic MB, Castle PE, Herrero R, et al: Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 66: 10112-10119, 2006.
24. Lapierre SG, Sauthier P, Mayrand MH, et al: Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 test for detection of high-grade lesions of the uterine cervix. J Clin Microbiol 50: 1240-1244, 2012.
25. Song SH, Hong JH, Kwak SH, Lee JK and Kim MK: Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples. J Obstet Gynaecol Res 38: 408-414, 2012.
26. Cortes J, Martinón-Torres F, Ramony Cajal JM, et al: Primary and secondary prevention of cervical cancers and vulva: recommendations for clinical practice. Prog Obstet Gynecol 53 (Suppl 1): 1-19, 2010. (In Spanish).
27. Wong AA, Fuller J, Pabbaraju K, Wong S and Zaharadia G: Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. J Clin Microbiol 50: 25-29, 2012.